We appreciate your interest in learning more about Lonza’s portfolio of products for immunology.
Assays utilizing immune cells are important in basic research and in each stage of immuno-oncology therapeutic development, from early discovery to translational validation. Cell-based assays are used for lead candidate selection, mode of action (MOA) analysis, safety, efficacy, toxicity testing, and off-target effect measurements. Complete the form here to gain access to a compilation of cell based assay protocols, including:
- B-ALI Immune-Airway Co-Culture Model: Normal Human Bronchial Epithelial Cells and Peripheral Blood Mononuclear Cells
- Dendritic Cells (DC) and T Cell Assay from Match PBMCs
- Macrophage Polarization and Phagocytosis Assay
